Medical progress: Polycystic ovary syndrome

被引：1416

作者：

Ehrmann, DA ^{[1
]}

机构：

[1] Univ Chicago, Dept Med, Endocrinol Sect, Chicago, IL 60637 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 352卷 / 12期

关键词：

D O I：

10.1056/NEJMra041536

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：1223 / 1236

页数：14

相关论文

共 145 条

[71] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, R ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Cleeman, JI ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ ;

Keller, SA ;

Jehle, AJ .

CIRCULATION, 2002, 106 (25) :3143-3421

[72] Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: A clinical, endocrinological, metabolic pilot study [J].

Guido, M ;

Romualdi, D ;

Giuliani, M ;

Suriano, R ;

Selvaggi, L ;

Apa, R ;

Lanzone, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2817-2823

[73] A PULSATILE GONADOTROPIN-RELEASING-HORMONE STIMULUS IS REQUIRED TO INCREASE TRANSCRIPTION OF THE GONADOTROPIN SUBUNIT GENES - EVIDENCE FOR DIFFERENTIAL REGULATION OF TRANSCRIPTION BY PULSE FREQUENCY INVIVO [J].

HAISENLEDER, DJ ;

DALKIN, AC ;

ORTOLANO, GA ;

MARSHALL, JC ;

SHUPNIK, MA .

ENDOCRINOLOGY, 1991, 128 (01) :509-517

[74]

Hardiman P, 2003, LANCET, V362, P1082

[75] The androgen-receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome [J].

Hickey, T ;

Chandy, A ;

Norman, RJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) :161-165

[76] A randomized, 48-week, placebocontrolled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study [J].

Hoeger, KM ;

Kochman, L ;

Wixom, N ;

Craig, K ;

Miller, RK ;

Guzick, DS .

FERTILITY AND STERILITY, 2004, 82 (02) :421-429

[77] Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: Role of insulin sensitivity and luteinizing hormone [J].

Huber-Buchholz, MM ;

Carey, DGP ;

Norman, RJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04) :1470-1474

[78] Polycystic ovary syndrome after precocious pubarche:: ontogeny of the low-birthweight effect [J].

Ibáñez, L ;

Valls, C ;

Potau, N ;

Marcos, MV ;

de Zegher, F .

CLINICAL ENDOCRINOLOGY, 2001, 55 (05) :667-672

[79] QUANTIFICATION OF THE RELATIONSHIP BETWEEN INSULIN SENSITIVITY AND BETA-CELL FUNCTION IN HUMAN-SUBJECTS - EVIDENCE FOR A HYPERBOLIC FUNCTION [J].

KAHN, SE ;

PRIGEON, RL ;

MCCULLOCH, DK ;

BOYKO, EJ ;

BERGMAN, RN ;

SCHWARTZ, MW ;

NEIFING, JL ;

WARD, WK ;

BEARD, JC ;

PALMER, JP ;

PORTE, D .

DIABETES, 1993, 42 (11) :1663-1672

[80] Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS [J].

Kahsar-Miller, MD ;

Nixon, C ;

Boots, LR ;

Go, RC ;

Azziz, R .

FERTILITY AND STERILITY, 2001, 75 (01) :53-58

← 3 4 5 6 7 8 9 10 11 12 →